Shenzhen TargetRx
Shenzhen TargetRx a Sino-American joint venture, high-tech pharmaceutical research and development company.
Launch date
Market cap
-
Enterprise valuation
€77—116m (Dealroom.co estimates May 2020.)
Shenzhen Guangdong (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
* | $21.2m | Series A | |
| Total Funding | €19.3m | ||
Related Content
Recent News about Shenzhen TargetRx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.